CYTOMEL
Live / Registered — Registered and renewed (as of 11 Jun 2018)
What this means for you
Registered since 23 Jun 1998. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 23 Jun 2018).
Record
- Serial number
- 75274531
- Registration number
- 2167335
- Mark type
- Word mark
- Filed
- 14 Apr 1997
- Published for opposition
- 31 Mar 1998
- Registered
- 23 Jun 1998
- Next maintenance due
- 23 Jun 2018
- Attorney of record
- Andrea Christensen
Goods and services
- Class 005 — Pharmaceuticals: hormone preparations for use as a metabolic stimulant
Owner
- KING PHARMACEUTICALS RESEARCH AND DEVELO, New York, NY, US
- KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC., Cary, NC, US
- JONES PHARMA INCORPORATED, BRISTOL, VA, US
- JONES MEDICAL INDUSTRIES, INC., St. Louis, MO, US
- JONES MEDICAL INDUSTRIES, INC., St. Louis, MO, US
- JONES MEDICAL INDUSTRIES, INC., St. Louis, MO, US
- SmithKline Beecham Corporation, Philadelphia, PA, US
Prosecution history
- 29 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Mar 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Mar 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Mar 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Mar 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Jun 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 11 Jun 2018 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 11 Jun 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 09 Jun 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 31 May 2018 — TEAS SECTION 8 & 9 RECEIVED
- 27 Dec 2017 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP